Data Supplement from SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

Abstract

Supplementary Figure S2. Close-up view of the salt-bridges interactions between huCD38 and the heavy-chain of SAR650984-Fab